Objective
This study aims to examine whether effects of dementia severity on Medicare expenditures differed for individuals with different levels of comorbidities.
Methods
Data are drawn from the Washington Heights-Inwood Columbia Aging Project (WHICAP), a multiethnic, population-based, prospective study of cognitive aging (N=1,927). Comprehensive clinical assessments of dementia severity were systematically carried out at approximately 18 month intervals. Dementia severity was measured by Clinical Dementia Rating (CDR) at each assessment. Comorbidities were measured by a modified Elixhauser comorbidities index. Generalized linear models examined effects of dementia severity, comorbidities, and their interactions on Medicare expenditures (1999–2010).
Results
At baseline, 1,280 subjects were dementia free (CDR=0, 66.4%), 490 had very mild dementia (CDR=0.5, 25.4%), 108 had mild dementia (CDR=1, 5.6%), 33 had moderate dementia (CDR=2, 1.7%), and the rest 16 had severe dementia (CDR=3, 0.8%). Average annual Medicare expenditures for individuals with moderate/severe dementia were more than twice as high as those who did not have dementia (CDR=0: $9,108, CDR=0.5/1: $11,664, CDR≥2: $19,604, p<0.01). Expenditures were approximately 10 times higher among those with ≥3 comorbidities than among those with no comorbidities to ($2,612 for those with no comorbidities, to $6,109 for those with 1, $10,656 for those with 2, and $30,244 for those with ≥3 comorbidities, p<0.001). Multivariate estimates showed that dementia severity was associated with higher expenditures, but comorbidities were the most important predictor of expenditures. We did not find strong interaction effects between number of comorbidities and dementia severity.
Conclusions
Increasing dementia severity and higher comorbidities are associated with higher Medicare expenditures. Care of individuals with dementia should focus on management of comorbidities.